Ποια είναι η τιμή για G&E Herbal Biotechnology Co., Ltd. (4911)

Η τιμή για G&E Herbal Biotechnology Co., Ltd. (4911) είναι $0.91899191

Ποια είναι η κεφαλαιοποίηση αγοράς για G&E Herbal Biotechnology Co., Ltd. (4911)

Η κεφαλαιοποίηση αγοράς για G&E Herbal Biotechnology Co., Ltd. (4911) είναι $63.24M

G&E Herbal Biotechnology Co., Ltd. (4911) Τιμή και Κεφαλαιοποίηση Αγοράς

G&E Herbal Biotechnology Co., Ltd. operates as a biopharmaceutical enterprise, concentrating on the innovation and commercialization of advanced botanical extraction technologies and the products derived from them. Its diverse portfolio features a range of botanical anti-aging cosmetic items, including facial foam cleansers, cleansing essences, toners, lightening lotions, essential oils, and moisturizing serums and creams, along with specialized products like the SR-100 botanical essence and bromelain illuminating cleansing mousse. The company also manufactures capsules designed as hepato-protective agents. In the realm of wellness, G&E offers a selection of botanical healthcare products such as ArthrEnergy, Jujubes Polysaccharide, Diabecut, HepatoClean, Astragali Radix, Goji, Prosta, and SR-100 capsules, as well as various products catering to adults. Looking to its future developments, the company is actively pursuing new treatments, including Solarise injection for gynecologic, head, and neck cancers; Apocin capsules intended for non-small cell lung cancer; and SR-T100 Gel, which targets common and genital warts. Beyond its own product lines, G&E Herbal Biotechnology is involved in creating manufacturing technologies for a wide array of dietary supplements and provides expert technical advisory services to other biotechnology organizations. The company was founded in 2002 and is headquartered in Tainan City, Taiwan.

Η τιμή για 4911	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$75,728.13 $63.24M	NVDA	$5.211T	+8,240,248.10%
$66,070.28 $63.24M	AAPL	$4.547T	+7,189,329.58%
$60,486.32 $63.24M	GOOG	$4.162T	+6,581,712.11%
$52,208.04 $63.24M	MSFT	$3.593T	+5,680,911.43%
$40,583.89 $63.24M	AMZN	$2.793T	+4,416,031.78%

Η τιμή για 4911

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$75,728.13 $63.24M